Ani Pharmaceuticals (ANIP) Current Taxes (2013 - 2026)
Ani Pharmaceuticals (ANIP) posted Current Taxes of $5.3 million for Q1 2026, up 136.58% sequentially from $2.2 million in Q4 2025, and down 62.67% YoY from $14.2 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Current Taxes (2013 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Current Taxes for 13 years, with the latest figure at $5.3 million in Q1 2026.
- Quarterly Current Taxes fell 62.67% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (down 62.67% YoY) and the FY2025 annual result came in at $2.2 million, down 60.17% from the prior year.
- Current Taxes rose to $5.3 million in Q1 2026 per ANIP's latest filing, from $2.2 million in the prior quarter.
- Over five years, Current Taxes peaked at $14.2 million in Q1 2025 and troughed at $594000.0 in Q3 2023.
- A 4-year average of $6.4 million and a median of $5.5 million in 2024 frame the typical range for Current Taxes.
- The sharpest annual moves came in 2025 and 2026: Current Taxes rose 24.43% in 2025, then plunged 62.67% in 2026.
- Over 4 years, Current Taxes stood at $8.2 million in 2023, then tumbled by 31.14% to $5.6 million in 2024, then tumbled by 60.17% to $2.2 million in 2025, then surged by 136.58% to $5.3 million in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $5.3 million, $2.2 million, and $3.3 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -355.54 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 138.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 739.89 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 46.00 Mn |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 3.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.53 Mn |
| Mar 31, 2026 | 5.30 Mn |
| Dec 31, 2025 | 2.24 Mn |
| Jun 30, 2025 | 3.29 Mn |
| Mar 31, 2025 | 14.19 Mn |
| Dec 31, 2024 | 5.62 Mn |
| Mar 31, 2024 | 11.40 Mn |
| Dec 31, 2023 | 8.16 Mn |
| Sep 30, 2023 | 594,000.00 |
| Mar 31, 2021 | 3.66 Mn |
| Dec 31, 2020 | 3.91 Mn |
| Jun 30, 2020 | 8.29 Mn |
| Mar 31, 2020 | 15.22 Mn |
| Mar 31, 2019 | 3.45 Mn |
| Dec 31, 2018 | 5.02 Mn |
| Sep 30, 2018 | 318,000.00 |
| Mar 31, 2017 | 3.66 Mn |
| Dec 31, 2016 | 2.40 Mn |
| Mar 31, 2015 | 481,000.00 |
| Dec 31, 2014 | 4.25 Mn |